Our Quantum Dot-Oligonucleotide Conjugation Services support research teams developing fluorescent nanoprobes, hybridization sensors, multiplexed detection systems, and nucleic-acid-directed nanoparticle assemblies. Quantum dots offer size-tunable optical behavior and strong photostability, while DNA or RNA oligonucleotides provide sequence-specific molecular recognition. Combining the two requires more than a simple coupling reaction: surface ligand chemistry, oligonucleotide functionalization, spacer architecture, conjugation density, colloidal behavior, and post-conjugation optical performance all influence whether the final construct performs reliably.
We coordinate oligonucleotide preparation with oligonucleotide conjugation workflows and application-aware nanoparticle functionalization. Projects can be configured around amine/carboxyl coupling, thiol/maleimide chemistry, affinity-based assembly, or other feasible surface chemistries, followed by purification and analytical checks selected for the construct. The goal is to deliver a research-use quantum dot–oligonucleotide conjugate whose composition, dispersion behavior, and hybridization function are aligned with the intended assay rather than optimized in isolation.
Surface Chemistry Compatibility: Quantum dots may be supplied with carboxyl, amine, thiol-reactive, affinity, or polymeric surface coatings. The coupling route must match the available surface group without destabilizing the particle coating or introducing reaction conditions that compromise the oligonucleotide.
Oligonucleotide Accessibility: High loading is not automatically beneficial. Excessive surface density, short linkers, or unfavorable attachment geometry can limit target access and increase steric crowding. We review terminal functionality, spacer length, strand orientation, and target-binding requirements before coupling.
Colloidal Stability: Activation steps, salt, pH, and removal of stabilizing ligands can alter quantum dot dispersion. Process conditions are selected to reduce aggregation risk and to preserve practical handling in the final buffer used for research assays.
Optical Performance: Conjugation can change the local environment around a quantum dot and can influence brightness, quenching, or energy-transfer behavior. Projects intended for fluorescence or FRET readouts therefore require optical checks that are relevant to the final construct, not only chemical confirmation.
Purification of Mixed Species: Unreacted oligonucleotide, free linker, activated nanoparticle, and differently loaded conjugates can coexist after reaction. Purification strategy must account for particle size, surface charge, and construct stability while minimizing loss of usable material.
Our service modules can be combined for a complete conjugation project or selected individually when clients already have a defined quantum dot, oligonucleotide, or assay format.
When a project requires modified strands, we can coordinate amino functionalization, thiol functionalization, or broader DNA/RNA modification before nanoparticle coupling.
The preferred chemistry depends on the quantum dot surface, the available oligonucleotide handle, and how much control is required over spacing and orientation.
| Quantum Dot Surface | Oligonucleotide Handle | Typical Coupling Logic | Main Design Considerations | Useful When |
| Carboxyl-functional surface | Primary amine | EDC/NHS-mediated amide formation | Activation hydrolysis, pH control, colloidal stability, amine accessibility | A compact covalent linkage is desired and carboxylated particles are available |
| Maleimide-functional surface | Reduced thiol | Thiol–maleimide addition | Thiol oxidation, maleimide stability, linker orientation | Site-directed terminal coupling is preferred |
| Amine-functional surface | Thiol or other orthogonal handle | Heterobifunctional linker strategy | Crosslinker selection, intermediate purification, linker length | The particle and oligo require different reactive handles |
| Affinity-functional surface | Biotin or complementary affinity tag | High-affinity noncovalent assembly | Valency, spacer length, blocking, reversibility | A modular assembly or rapid feasibility format is useful |
| Click-compatible surface | Azide or strained alkyne partner | Chemoselective click coupling | Handle accessibility, reagent compatibility, surface coating tolerance | Orthogonal coupling is needed in a multifunctional construct |
These variables are reviewed together because improving one attribute, such as loading, can negatively affect accessibility, stability, or optical response.
| Parameter | Why It Matters | What We Review | Typical Risk | Project Output |
| Oligonucleotide density | Controls target accessibility and local crowding | Feed ratio, available surface sites, strand length | Overcrowding can reduce hybridization efficiency | Loading strategy and comparative conditions |
| Spacer architecture | Separates the strand from the nanoparticle surface | Alkyl versus hydrophilic spacer, terminal placement | Too little spacing can create steric restriction | Recommended linker/spacer configuration |
| Surface charge | Influences dispersion and nonspecific interactions | Coating composition, oligo charge contribution, buffer | Aggregation or elevated background | Buffer and handling recommendation |
| Optical behavior | Determines suitability for fluorescence-based readouts | Emission profile, relative intensity, quenching/FRET context | Signal changes after conjugation | Application-relevant optical check |
| Purification mode | Defines removal of free oligo and reagents | Size, charge, construct stability, volume | Poor separation or material loss | Purified conjugate and cleanup record |
| Hybridization function | Confirms that recognition is retained | Target accessibility, controls, assay conditions | Chemically conjugated but functionally inaccessible strand | Functional test plan or assay data when included |
The workflow is organized around early compatibility decisions so that nanoparticle stability and oligonucleotide function are considered before the coupling reaction.
We define the oligonucleotide sequence, quantum dot composition and coating, available reactive groups, target assay, and required final format. This establishes whether the project should use covalent coupling, affinity assembly, or another route.
We select oligonucleotide terminal functionality and spacer architecture, then review reaction compatibility with the quantum dot surface. The design is checked for steric access, buffer constraints, and the intended fluorescence or capture format.
The required modified DNA or RNA is synthesized or received from the client, purified as appropriate, and prepared for coupling. Reactive handles are managed to preserve activity prior to conjugation.
Coupling conditions are screened or executed using defined feed ratios, reaction pH, and timing. Where needed, comparative conditions are used to identify a workable balance between loading and particle stability.
The conjugate is separated from free oligonucleotide and small reagents, then evaluated using analytical methods suited to the construct. Optical and dispersion-related checks can be included when they are relevant to downstream performance.
Final material is supplied with the agreed analytical information, handling guidance, and project notes. We can also support subsequent probe optimization or assay integration when the first conjugate requires follow-on tuning.
A coordinated workflow reduces the common disconnect between nanoparticle surface chemistry and oligonucleotide design.
Quantum dot–oligonucleotide constructs are useful when sequence recognition must be coupled to a bright, nanoscale optical or surface-active label.
Whether your project starts with a specific quantum dot surface, a defined DNA/RNA probe, or an early sensing concept, our team can help align coupling chemistry, spacer design, purification, and functional characterization into a practical research workflow. Contact us to discuss your project requirements.
Common options include terminal amines, thiols, affinity tags, and click-compatible handles. The best choice depends on the quantum dot surface coating and the required attachment geometry.
EDC/NHS is commonly matched to carboxyl-functional quantum dots and amine-modified oligos, while thiol–maleimide coupling is useful for more site-directed terminal attachment. Particle stability and buffer compatibility are reviewed before selecting either route.
Yes. A spacer can move the oligonucleotide away from the nanoparticle surface and reduce steric crowding, but excessive length can add flexibility. Spacer selection should be tested against the intended assay.
The purification method is chosen according to particle size, surface charge, conjugate stability, and sample volume. Size-based, chromatographic, or other compatible separation approaches may be used.
Yes, if the particle composition, coating, concentration, storage buffer, and available reactive groups are sufficiently defined for a feasibility review.
Loading ......
